Abstract
The overexpression of the multidrug resistance (mdr1) gene and its product, P-glycoprotein (P-gp), is thought to limit the successful chemotherapy of human tumours. The mechanism by which mdr1 gene and P-gp are overexpressed in human tumours, however, is not yet clear. In this report, we show that the mdm2 (murine double minute 2) gene induced the expression of the mdr1 gene and P-gp in human glioblastoma U87-MG cells, which did not express the MDM2 protein or P-gp. The mdm2 gene, in addition, conferred the resistance of U87-MG cells to the apoptotic cell death induced by etoposide (VP-16) or doxorubicin. Furthermore, treatment with mdm2 antisense oligonucleotides inhibited the expression of P-gp in MDM2-expressing U87-MG cells. These findings suggest that the mdm2 gene may play an important role in the development of MDR phenotype in human tumours.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kondo, S., Kondo, Y., Hara, H. et al. mdm2 gene mediates the expression of mdr1 gene and P-glycoprotein in a human glioblastoma cell line. Br J Cancer 74, 1263–1268 (1996). https://doi.org/10.1038/bjc.1996.527
Issue Date:
DOI: https://doi.org/10.1038/bjc.1996.527
This article is cited by
-
Mdm2 selectively suppresses DNA damage arising from inhibition of topoisomerase II independent of p53
Oncogene (2017)
-
Low Dose of Doxorubicin Potentiates the Effect of Temozolomide in Glioblastoma Cells
Molecular Neurobiology (2017)
-
Clinical significance of MDM2 as a tumor biomarker
The Chinese-German Journal of Clinical Oncology (2012)
-
Quantitative PCR analysis of the expression profile of genes related to multiple drug resistance in tumors of the central nervous system
Journal of Neuro-Oncology (2007)
-
A modified p53 enhances apoptosis in sarcoma cell lines mediated by doxorubicin
British Journal of Cancer (2004)